VTX3232

· Zomagen Biosciences Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VTX3232, covering 2025-11-10 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study of VTX3232 in Parkinson's Disease [Phase 2]